Martingale Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.92M | Buy |
3,915
+137
| +4% | +$74.3K | 0.05% | 356 |
|
|
2025
Q4 | $2.19M | Buy |
3,778
+2,197
| +139% | +$1.24M | 0.06% | 295 |
|
|
2025
Q3 | $767K | Sell |
1,581
-2,451
| -61% | -$1.14M | 0.02% | 542 |
|
|
2025
Q2 | $1.63M | Sell |
4,032
-4,070
| -50% | -$1.7M | 0.04% | 343 |
|
|
2025
Q1 | $4.03M | Sell |
8,102
-808
| -9% | -$438K | 0.1% | 173 |
|
|
2024
Q4 | $4.64M | Buy |
8,910
+528
| +6% | +$290K | 0.11% | 156 |
|
|
2024
Q3 | $5.18M | Buy |
8,382
+7,271
| +654% | +$4.3M | 0.12% | 159 |
|
|
2024
Q2 | $614K | Buy |
+1,111
| New | +$636K | 0.01% | 560 |
|
|
2023
Q3 | – | Sell |
-1,245
| Closed | -$650K | – | 850 |
|
|
2023
Q2 | $650K | Buy |
1,245
+51
| +4% | +$27.5K | 0.01% | 554 |
|
|
2023
Q1 | $688K | Sell |
1,194
-2,734
| -70% | -$1.54M | 0.01% | 540 |
|
|
2022
Q4 | $2.16M | Sell |
3,928
-29,779
| -88% | -$15.8M | 0.04% | 249 |
|
|
2022
Q3 | $17.1M | Sell |
33,707
-2,691
| -7% | -$1.51M | 0.34% | 112 |
|
|
2022
Q2 | $19.8M | Sell |
36,398
-7,712
| -17% | -$4.24M | 0.36% | 106 |
|
|
2022
Q1 | $26.1M | Sell |
44,110
-2,766
| -6% | -$1.59M | 0.39% | 100 |
|
|
2021
Q4 | $31.3M | Sell |
46,876
-36,550
| -44% | -$22.8M | 0.4% | 100 |
|
|
2021
Q3 | $47.7M | Sell |
83,426
-13,401
| -14% | -$7.36M | 0.62% | 54 |
|
|
2021
Q2 | $48.8M | Sell |
96,827
-28,637
| -23% | -$13.5M | 0.56% | 69 |
|
|
2021
Q1 | $57.3M | Sell |
125,464
-2,098
| -2% | -$1M | 0.66% | 48 |
|
|
2020
Q4 | $59.4M | Buy |
127,562
+8,605
| +7% | +$4.03M | 0.67% | 45 |
|
|
2020
Q3 | $52.5M | Buy |
118,957
+41,693
| +54% | +$17.2M | 0.63% | 42 |
|
|
2020
Q2 | $28M | Buy |
77,264
+60,204
| +353% | +$20.2M | 0.33% | 99 |
|
|
2020
Q1 | $4.84M | Sell |
17,060
-900
| -5% | -$284K | 0.06% | 290 |
|
|
2019
Q4 | $5.83M | Sell |
17,960
-1,401
| -7% | -$425K | 0.06% | 347 |
|
|
2019
Q3 | $5.64M | Sell |
19,361
-5,750
| -23% | -$1.65M | 0.06% | 349 |
|
|
2019
Q2 | $7.38M | Sell |
25,111
-301
| -1% | -$82.9K | 0.08% | 281 |
|
|
2019
Q1 | $6.96M | Sell |
25,412
-1,440
| -5% | -$358K | 0.08% | 284 |
|
|
2018
Q4 | $6.01M | Sell |
26,852
-2,899
| -10% | -$680K | 0.08% | 266 |
|
|
2018
Q3 | $7.26M | Sell |
29,751
-1,100
| -4% | -$253K | 0.08% | 231 |
|
|
2018
Q2 | $6.39M | Sell |
30,851
-2,398
| -7% | -$509K | 0.08% | 248 |
|
|
2018
Q1 | $6.87M | Sell |
33,249
-88,775
| -73% | -$18.6M | 0.09% | 219 |
|
|
2017
Q4 | $23.2M | Sell |
122,024
-3,304
| -3% | -$633K | 0.31% | 116 |
|
|
2017
Q3 | $23.7M | Sell |
125,328
-6,798
| -5% | -$1.23M | 0.32% | 109 |
|
|
2017
Q2 | $23.1M | Sell |
132,126
-9,789
| -7% | -$1.64M | 0.33% | 105 |
|
|
2017
Q1 | $21.8M | Sell |
141,915
-4,200
| -3% | -$642K | 0.31% | 111 |
|
|
2016
Q4 | $20.6M | Sell |
146,115
-18,200
| -11% | -$2.68M | 0.29% | 119 |
|
|
2016
Q3 | $26.1M | Sell |
164,315
-11,704
| -7% | -$1.8M | 0.39% | 81 |
|
|
2016
Q2 | $26M | Buy |
176,019
+78,108
| +80% | +$11.5M | 0.43% | 82 |
|
|
2016
Q1 | $13.9M | Buy |
97,911
+8,500
| +10% | +$1.14M | 0.27% | 129 |
|
|
2015
Q4 | $12.7M | Buy |
89,411
+50,652
| +131% | +$6.76M | 0.28% | 126 |
|
|
2015
Q3 | $4.74M | Buy |
38,759
+12,850
| +50% | +$1.67M | 0.12% | 222 |
|
|
2015
Q2 | $3.36M | Buy |
+25,909
| New | +$3.38M | 0.08% | 252 |
|
Other funds holding TMO
VCM
Martingale Asset Management's TMO Position: Q1 2026 in Review
Martingale Asset Management increased its Thermo Fisher Scientific (TMO) stake by 3.6% in Q1 2026, buying an estimated $74.3K and bringing the position to 3,915 shares worth $1.92M. The position accounts for 0.05% of the portfolio, ranked #356.
Martingale Asset Management first reported a position in TMO in Q2 2015 and has held it in 41 quarters since. The position peaked at $59.4M in Q4 2020. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Martingale Asset Management held 3,915 shares of Thermo Fisher Scientific worth $1.92M as of Q1 2026.
- Martingale Asset Management bought 137 Thermo Fisher Scientific shares in Q1 2026, an estimated $74.3K.
- Thermo Fisher Scientific made up 0.05% of Martingale Asset Management's portfolio in Q1 2026, its #356 holding.
- Martingale Asset Management first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 41 quarters since.
- Martingale Asset Management's Thermo Fisher Scientific position peaked at $59.4M in Q4 2020.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.